Related Experiment Videos
Hemostatic function and carotid artery disease
C Liapis1, J Kakisis, V Papavassiliou
1Second Department of Propedeutic Surgery, Athens University Medical School, Athens, Greece.
Summary
Clotting factors like tissue plasminogen activator and PAI-1 are linked to carotid artery disease development. However, these hemostatic factors do not predict cerebrovascular events in patients with carotid stenosis.
Area of Science:
- Cardiovascular Research
- Hematology
- Neuroscience
Background:
- Conventional cardiovascular risk factors explain less than half of cardiovascular events.
- Atherogenesis involves complex pathways beyond traditional risk factors.
- The role of hemostatic factors in carotid artery disease requires further investigation.
Purpose of the Study:
- To investigate the association between clotting factors and carotid artery disease.
- To determine if clotting factors can predict cerebrovascular event risk in internal carotid artery stenosis patients.
Main Methods:
- Evaluated 26 patients with high-grade internal carotid artery stenosis and 43 age-matched controls.
- Assessed atherogenic risk factors and hemostatic function, including fibrinogen, tissue plasminogen activator (TPA), D-dimer, plasminogen activator inhibitor 1 (PAI-1), plasminogen, and factor VII:c.
- Utilized multiple linear regression analysis for statistical evaluation.
Main Results:
- Carotid artery stenosis showed significant association with elevated TPA, D-dimer, and PAI-1 levels.
- No significant correlation was found between carotid artery disease and fibrinogen, plasminogen, or factor VII:c levels.
- None of the assessed clotting factors correlated with cerebrovascular event history in patients with carotid stenosis.
Conclusions:
- The hemostatic system appears to contribute to the development of atherosclerotic carotid artery disease.
- Hemostatic factors do not seem to influence symptom development in patients with carotid stenosis.
- Further research is needed to elucidate the precise role of hemostasis in carotid artery disease progression and outcomes.